Open AccessBaloxavir Marboxil 2% Granules in Japanese Children With Influenza
Author(s) -
Takato Yokoyama,
Hiroki Sakaguchi,
Tôru Ishibashi,
Toetsu Shishido,
Pedro A. Piedra,
Chisako Sato,
Kenji J. Tsuchiya,
Takeki Uehara
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002748
Subject(s) - medicine , discontinuation , adverse effect , regimen , titer , virus , confidence interval , influenza a virus , viral load , gastroenterology , immunology
A granule formulation of baloxavir marboxil, a selective inhibitor of influenza cap-dependent endonuclease, was newly developed for children with difficulty swallowing tablets.